The LINX® reflux management system: confirmed safety and efficacy now at 4 years
- 27 April 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 26 (10), 2944-2949
- https://doi.org/10.1007/s00464-012-2289-1
Abstract
Sphincter augmentation with the LINX® Reflux Management System is a surgical option for patients with chronic gastroesophageal disease (GERD) and an inadequate response to proton pump inhibitors (PPIs). Clinical experience with sphincter augmentation is now available out to 4 years.This publication has 17 references indexed in Scilit:
- Nissen Fundoplication after Failure of Endoluminal Fundoplication: Short-Term ResultsJournal of Gastrointestinal Surgery, 2011
- Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP)Gastrointestinal Endoscopy, 2010
- Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal DiseasesGastroenterology, 2009
- Systematic review of endoscopic treatments for gastro-oesophageal reflux diseaseBritish Journal of Surgery, 2009
- Gastroesophageal Reflux DiseaseNew England Journal of Medicine, 2008
- Use of a magnetic sphincter for the treatment of GERD: a feasibility studyGastrointestinal Endoscopy, 2008
- Transient Lower Esophageal Sphincter Relaxations and Reflux: Mechanistic Analysis Using Concurrent Fluoroscopy and High-Resolution ManometryGastroenterology, 2006
- Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoringGut, 2006
- Development of the 24-Hour Intraesophageal pH Monitoring Composite Scoring SystemJournal of Clinical Gastroenterology, 1986
- A New Concept in the Surgical Treatment of Gastroesophageal RefluxAnnals of Surgery, 1983